Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinomaCentral MessagePerspective

Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinomaCentral MessagePerspective

Objectives: Neoadjuvant chemoradiation has been shown to improve survival in locally advanced esophageal and gastroesophageal junction cancer. The purpose of our study was to examine the effects of posttreatment persistent lymph node (LN) disease on overall survival (OS) and recurrence in patients w...

Full description

Bibliographic Details
Main Authors: Apostolos Kandilis, MD, Carlos Bravo Iniguez, MD, Hassan Khalil, MD, Emanuele Mazzola, MS, PhD, Michael T. Jaklitsch, MD, Scott J. Swanson, MD, Raphael Bueno, MD, Jon O. Wee, MD
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:JTCVS Open
Subjects:
esophageal cancer
adenocarcinoma esophagus
nodal disease
persistent nodal disease
adjuvant therapy
pathologic staging
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273620301789

Internet

http://www.sciencedirect.com/science/article/pii/S2666273620301789

Similar Items